Sinopharm, China's biggest pharmaceuticals distributor, saw its shares jump nearly 16 per cent on its market debut in Hong Kong yesterday, as investors hoped that the country's healthcare reform could spur growth.
manbetx3.0 最大的医药分销商国药控股(Sinopharm)昨日在香港上市首日大涨近16%，投资者期望manbetx3.0 的医疗改革能刺激医药板块的增长。
您已阅读14%（277字），剩余86%（1687字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。